Skip to main content

Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation

Publication ,  Conference
Field, ME; Rahman, M; Goldstein, L; Maccioni, S; Srivastava, A; Khanna, R; Piccini, JP; Friedman, DJ
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2020

Duke Scholars

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

2020

Volume

29

Start / End Page

353 / 354

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Field, M. E., Rahman, M., Goldstein, L., Maccioni, S., Srivastava, A., Khanna, R., … Friedman, D. J. (2020). Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 29, pp. 353–354).
Field, Michael E., Motiur Rahman, Laura Goldstein, Sonia Maccioni, Abhishek Srivastava, Rahul Khanna, Jonathan P. Piccini, and Daniel J. Friedman. “Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 29:353–54, 2020.
Field ME, Rahman M, Goldstein L, Maccioni S, Srivastava A, Khanna R, et al. Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 353–4.
Field, Michael E., et al. “Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 29, 2020, pp. 353–54.
Field ME, Rahman M, Goldstein L, Maccioni S, Srivastava A, Khanna R, Piccini JP, Friedman DJ. Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 353–354.

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

2020

Volume

29

Start / End Page

353 / 354

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences